Goldman Sachs, Morgan Stanley downgrade China stocks

Goldman Sachs economists released an analysis that projected that President-elect Trump's tax cuts and deregulation will ...
Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $137.00. The company’s shares closed last Friday at $99.72.
Goldman Sachs Research predicts a strong year for global economic growth in 2025, forecasting a 2.7% increase in global GDP ...
Wall Street investment banking giant Goldman Sachs holds more than $700 million in spot Bitcoin ETF (exchange-traded fund) ...
The Wall Street giant set out to build a marketing 'army' under its first CMO. Some high-level insiders question whether it's ...
Goldman Sachs said it now expects the Bank of England to take a slower approach to interest-rate cuts after the UK budget ...
Wall Street giant Goldman Sachs has revealed in a new filing with the U.S .Securities and Exchange Commission that it ...
There were celebrations across Goldman Sachs last week after it promoted 95 executives to partner. Here's how nine new ...
Hedge funds ended the week as net buyers of stocks in U.S. financial and healthcare companies, according to ...